Author: Customer Service

Post-Quantum Encryption Transition Expected to Drive a Multi-Year Global Cybersecurity Upgrade Cycle LAKEWOOD, NJ, Feb. 23, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: EZRA) (“we,” “us,” our,” the “Company” or “Reliance”) today announced the  completion of its strategic acquisition of Enquantum Ltd., a post-quantum cryptography company developing quantum-resilient encryption technology. The transaction marks the first active platform acquisition executed under EZRA’s Scale51 operating model and establishes a defined pathway toward majority control as the Company moves to build Enquantum into a core operating platform within EZRA International Group. Quantum computing advancement is accelerating globally, intensifying concern that widely deployed encryption standards such as Rivest-Shamir-Adleman (RSA) and Elliptic...

Oslo, Norway 23 February 2026 – An extraordinary general meeting of PCI Biotech Holding ASA (‘PCI Biotech’ or ‘Company’) will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 16 March 2026 at 10:00am (CET). The proposed resolutions include company dissolution and delisting from Euronext Oslo Børs. The Board of Directors’ proposed resolution to dissolve PCI Biotech is made as there is no longer any operational activity in the Company, nor is it expected that it will resume such activity or other activities. The wholly owned subsidiary, PCI Biotech AS, has today resolved to initiate a parallel dissolution process. The Board of Directors’ proposed resolution to delist the shares from Euronext Oslo Børs is made based on the non-existent operational activity and limited asset base. It is in the view of the Board of...

23 February 2026LEI: 2138003QW2ZAYZODBU23 LSE Code: 2UKS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE FTSE 100 2X DAILY SHORT SECURITIESISIN: IE00B94QKF15 NOTICE OF CORRECTION TO NOTICE DATED 18 FEBRUARY 2026 IN RESPECT OF TIME OF MEETING RELATING TO A PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES We refer to a notice issued by the Issuer dated 18 February 2026 (the “Original Notice”) convening a meeting of the holders of the Affected Securities (the “Meeting”) to consider certain amendments to the documentation required to effect a reduction in the principal amount of the Affected Securities. We also refer to an explanatory letter from the Issuer providing further details on the proposed principal amount reduction dated 18 February...

Ra’anana, Israel, Feb. 23, 2026 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company focused on transforming railway safety and the rail data markets seeking, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Company had previously announced that it was notified by Nasdaq on September 3, 2025, that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), as the closing bid price of the Company’s common shares had been below $1.00 for more than 30 consecutive business...

Company announcement no. 2-2026 23 February 2026 North Media announces preliminary, unaudited financial results for 2025 as well as the financial guidance for 2026. Preliminary and unaudited financial results for 2025 and guidance for 2026DKKm 2025 Guidance for 2026Revenue 1,296 1,267 – 1,333EBITDA 125 133 – 175EBIT 66 75 – 117North Media delivered revenue and operating profit (EBIT) for 2025 in the line with the latest guidance, which amounted to revenue of DKKm 1,270 – 1,305, an EBITDA of DKKm 105 – 126 and an EBIT of DKKm 50 – 70. North Medias revenue was in line with 2024. In Last Mile (FK Distribution and SDR) the revenue fell by 1% to DKK 1,132m., due to an expected decrease FK Distribution’s volume. Despite a significant decrease in volume, SDR increased its revenue by 2%, mainly driven by the insourcing of...

WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in two upcoming March conferences.TD Cowen 46th Annual Healthcare Conference:Management will present and participate in a fireside chat on March 3, 2026, at 11:50 AM ET taking place in Boston, Massachusetts.Barclays 28th Annual Global Healthcare Conference:Management will participate in a fireside chat on March 10, 2026 at 8:00 AM ET taking place in Miami, Florida.The live webcasts will be available on the Investors section of the company’s website at www.c4therapeutics.com. The archived replays of the webcasts will be available for approximately 90 days following...

KBLB National Geographic March 2026 coverKraig Biocraft Laboratories (OTCQB: KBLB) groundbreaking spider silk commercialization work is featured on National Geographic’s March 2026 coverANN ARBOR, Mich., Feb. 23, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine. National Geographic highlights Kraig Labs’ advancements in producing spider silk fibers using genetically enhanced silkworms. The article includes a graphic that describes the significant advantages of a silkworm-based platform (Kraig Labs Technology)....

~ uniQure to host earnings call on Monday, March 2, 2026 at 8:00 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, Feb. 23, 2026 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report fourth quarter and full year of 2025 financial results before market open on Monday, March 2, 2026. Management will then host a conference call at 8:00 a.m. ET. The event will be webcast under the Events & Presentations section of uniQure’s website at https://www.uniqure.com/investors-media/events-presentations, and following the event a replay will be archived for 90 days. Analysts wishing to participate in the question and answer session should access the live call by dialing (646) 307-1963 or toll-free (800) 715-9871 and entering conference...